Annual report
2533.TEDINET S100QBP5
Period2020-01-01 → 2020-12-31
Filed2023-03-03
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amends S100KZT4.
Key figures · 147
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥77.7bn | 2020-01-01 → 2020-12-31 | Cons. | Net sales |
| Revenue | ¥75.4bn | 2019-01-01 → 2019-12-31 | Cons. | Net sales |
| Revenue | ¥77.2bn | 2018-01-01 → 2018-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥78.7bn | 2017-01-01 → 2017-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥79.2bn | 2016-01-01 → 2016-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.2bn | 2020-01-01 → 2020-12-31 | Cons. | Operating income |
| Operating income | ¥1.8bn | 2019-01-01 → 2019-12-31 | Cons. | Operating income |
| Ordinary income | ¥2.2bn | 2020-01-01 → 2020-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.7bn | 2019-01-01 → 2019-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.6bn | 2018-01-01 → 2018-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.9bn | 2017-01-01 → 2017-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.9bn | 2016-01-01 → 2016-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.8bn | 2020-01-01 → 2020-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.6bn | 2019-01-01 → 2019-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.1bn | 2020-01-01 → 2020-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.1bn | 2019-01-01 → 2019-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥469m | 2018-01-01 → 2018-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.3bn | 2017-01-01 → 2017-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥610m | 2016-01-01 → 2016-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.2bn | 2020-01-01 → 2020-12-31 | Cons. | Profit loss |
| Net income | ¥1.2bn | 2019-01-01 → 2019-12-31 | Cons. | Profit loss |
| Total assets | ¥51.7bn | at 2020-12-31 | Cons. | Assets |
| Total assets | ¥52.6bn | at 2019-12-31 | Cons. | Assets |
| Total assets | ¥53.3bn | at 2018-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥54.5bn | at 2017-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥52.3bn | at 2016-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥29.6bn | at 2020-12-31 | Cons. | Liabilities |
| Total liabilities | ¥30.7bn | at 2019-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥22.1bn | at 2020-12-31 | Cons. | Net assets |
| Net assets / equity | ¥21.8bn | at 2019-12-31 | Cons. | Net assets |
| Net assets / equity | ¥21.2bn | at 2018-12-31d | Cons. | Net assets |
| Net assets / equity | ¥21.3bn | at 2017-12-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥20.9bn | at 2016-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥915m | at 2020-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.2bn | at 2019-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥910m | at 2020-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2019-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2018-12-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2017-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.9bn | at 2016-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥4.8bn | 2020-01-01 → 2020-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.9bn | 2019-01-01 → 2019-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.7bn | 2018-01-01 → 2018-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.1bn | 2017-01-01 → 2017-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.2bn | 2016-01-01 → 2016-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥3.5bn | 2020-01-01 → 2020-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.3bn | 2019-01-01 → 2019-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥3.0bn | 2018-01-01 → 2018-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.0bn | 2017-01-01 → 2017-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥535m | 2016-01-01 → 2016-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥1.5bn | 2020-01-01 → 2020-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.7bn | 2019-01-01 → 2019-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥828m | 2018-01-01 → 2018-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.7bn | 2017-01-01 → 2017-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.5bn | 2016-01-01 → 2016-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥19.26 | 2020-01-01 → 2020-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.28 | 2019-01-01 → 2019-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.77 | 2018-01-01 → 2018-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.82 | 2017-01-01 → 2017-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥9.75 | 2016-01-01 → 2016-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥336.41 | at 2020-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥328.38 | at 2019-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥315.65 | at 2018-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥317.39 | at 2017-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥302.5 | at 2016-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 38.7% | at 2020-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.6% | at 2019-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.8% | at 2018-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.2% | at 2017-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.9% | at 2016-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 5.8% | 2020-01-01 → 2020-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.7% | 2019-01-01 → 2019-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.5% | 2018-01-01 → 2018-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.7% | 2017-01-01 → 2017-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.3% | 2016-01-01 → 2016-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 908 | at 2020-12-31 | Cons. | Number of employees |
| Employees | 906 | at 2019-12-31 | Cons. | Number of employees |
| Employees | 947 | at 2018-12-31d | Cons. | Number of employees |
| Employees | 955 | at 2017-12-31d | Cons. | Number of employees |
| Employees | 959 | at 2016-12-31d | Cons. | Number of employees |
| Revenue | ¥2.5bn | 2020-01-01 → 2020-12-31 | Standalone | Net sales |
| Revenue | ¥2.5bn | 2019-01-01 → 2019-12-31 | Standalone | Net sales |
| Revenue | ¥2.6bn | 2018-01-01 → 2018-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.5bn | 2017-01-01 → 2017-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.6bn | 2016-01-01 → 2016-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.1bn | 2020-01-01 → 2020-12-31 | Standalone | Operating income |
| Operating income | ¥905m | 2019-01-01 → 2019-12-31 | Standalone | Operating income |
| Ordinary income | ¥1.0bn | 2020-01-01 → 2020-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥853m | 2019-01-01 → 2019-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥625m | 2018-01-01 → 2018-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥166m | 2017-01-01 → 2017-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥394m | 2016-01-01 → 2016-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥717m | 2020-01-01 → 2020-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.1bn | 2019-01-01 → 2019-12-31 | Standalone | Income before income taxes |
| Net income | ¥716m | 2020-01-01 → 2020-12-31 | Standalone | Profit loss |
| Net income | ¥979m | 2019-01-01 → 2019-12-31 | Standalone | Profit loss |
| Net income | ¥87m | 2018-01-01 → 2018-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥85m | 2017-01-01 → 2017-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥507m | 2016-01-01 → 2016-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥33.4bn | at 2020-12-31 | Standalone | Assets |
| Total assets | ¥33.2bn | at 2019-12-31 | Standalone | Assets |
| Total assets | ¥33.3bn | at 2018-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥33.9bn | at 2017-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥32.8bn | at 2016-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥17.3bn | at 2020-12-31 | Standalone | Liabilities |
| Total liabilities | ¥16.9bn | at 2019-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥16.2bn | at 2020-12-31 | Standalone | Net assets |
| Net assets / equity | ¥16.3bn | at 2019-12-31 | Standalone | Net assets |
| Net assets / equity | ¥15.9bn | at 2018-12-31d | Standalone | Net assets |
| Net assets / equity | ¥16.3bn | at 2017-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥17.1bn | at 2016-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥120m | at 2020-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥145m | at 2019-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥12.03 | 2020-01-01 → 2020-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.21 | 2019-01-01 → 2019-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1.45 | 2018-01-01 → 2018-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1.42 | 2017-01-01 → 2017-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.09 | 2016-01-01 → 2016-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥7 | 2020-01-01 → 2020-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥7 | 2019-01-01 → 2019-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥7 | 2018-01-01 → 2018-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥7 | 2017-01-01 → 2017-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥7 | 2016-01-01 → 2016-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥272.03 | at 2020-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥270.67 | at 2019-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥262.74 | at 2018-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥270.12 | at 2017-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥275.82 | at 2016-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 48.4% | at 2020-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.1% | at 2019-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.7% | at 2018-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.1% | at 2017-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.1% | at 2016-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 4.4% | 2020-01-01 → 2020-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.1% | 2019-01-01 → 2019-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 0.5% | 2018-01-01 → 2018-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 0.5% | 2017-01-01 → 2017-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 65,586,196 | at 2020-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 65,586,196 | at 2019-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 65,586,196 | at 2018-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 65,586,196 | at 2017-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 65,586,196 | at 2016-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 44 | at 2020-12-31 | Standalone | Number of employees |
| Employees | 46 | at 2019-12-31 | Standalone | Number of employees |
| Employees | 51 | at 2018-12-31d | Standalone | Number of employees |
| Employees | 49 | at 2017-12-31d | Standalone | Number of employees |
| Employees | 55 | at 2016-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 88
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2020-01-01 → 2020-12-31 | ¥0 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2020-01-01 → 2020-12-31 | ¥72m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2020-01-01 → 2020-12-31 | ¥72m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2020-12-31 | ¥58m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2020-01-01 → 2020-12-31 | ¥13m |
| Reconciling Itemsreconciling | capex | 2020-01-01 → 2020-12-31 | ¥558m |
| Reconciling Itemsreconciling | depreciation | 2020-01-01 → 2020-12-31 | ¥220m |
| Reconciling Itemsreconciling | revenue | 2020-01-01 → 2020-12-31 | −¥9m |
| Reconciling Itemsreconciling | revenue intersegment | 2020-01-01 → 2020-12-31 | −¥9m |
| Reconciling Itemsreconciling | segment assets | at 2020-12-31 | ¥3.7bn |
| Enzymatic Medicinereportable segment | capex | 2020-01-01 → 2020-12-31 | ¥141m |
| Enzymatic Medicinereportable segment | depreciation | 2020-01-01 → 2020-12-31 | ¥246m |
| Enzymatic Medicinereportable segment | employees | at 2020-12-31 | 119 pure |
| Enzymatic Medicinereportable segment | revenue | 2020-01-01 → 2020-12-31 | ¥3.3bn |
| Enzymatic Medicinereportable segment | revenue external | 2020-01-01 → 2020-12-31 | ¥3.3bn |
| Enzymatic Medicinereportable segment | segment assets | at 2020-12-31 | ¥3.8bn |
| Enzymatic Medicinereportable segment | segment profit | 2020-01-01 → 2020-12-31 | ¥591m |
| Liquorreportable segment | capex | 2020-01-01 → 2020-12-31 | ¥937m |
| Liquorreportable segment | depreciation | 2020-01-01 → 2020-12-31 | ¥1.2bn |
| Liquorreportable segment | employees | at 2020-12-31 | 717 pure |
| Liquorreportable segment | revenue | 2020-01-01 → 2020-12-31 | ¥70.4bn |
| Liquorreportable segment | revenue external | 2020-01-01 → 2020-12-31 | ¥70.4bn |
| Liquorreportable segment | revenue intersegment | 2020-01-01 → 2020-12-31 | ¥9m |
| Liquorreportable segment | segment assets | at 2020-12-31 | ¥40.2bn |
| Liquorreportable segment | segment profit | 2020-01-01 → 2020-12-31 | ¥1.3bn |
| Real Estatereportable segment | capex | 2020-01-01 → 2020-12-31 | ¥8m |
| Real Estatereportable segment | depreciation | 2020-01-01 → 2020-12-31 | ¥34m |
| Real Estatereportable segment | employees | at 2020-12-31 | 1 pure |
| Real Estatereportable segment | revenue | 2020-01-01 → 2020-12-31 | ¥351m |
| Real Estatereportable segment | revenue external | 2020-01-01 → 2020-12-31 | ¥351m |
| Real Estatereportable segment | segment assets | at 2020-12-31 | ¥1.7bn |
| Real Estatereportable segment | segment profit | 2020-01-01 → 2020-12-31 | ¥186m |
| Starch For Processingreportable segment | capex | 2020-01-01 → 2020-12-31 | ¥61m |
| Starch For Processingreportable segment | depreciation | 2020-01-01 → 2020-12-31 | ¥62m |
| Starch For Processingreportable segment | employees | at 2020-12-31 | 29 pure |
| Starch For Processingreportable segment | revenue | 2020-01-01 → 2020-12-31 | ¥3.6bn |
| Starch For Processingreportable segment | revenue external | 2020-01-01 → 2020-12-31 | ¥3.6bn |
| Starch For Processingreportable segment | segment assets | at 2020-12-31 | ¥2.2bn |
| Starch For Processingreportable segment | segment profit | 2020-01-01 → 2020-12-31 | ¥148m |
| —segment total | capex | 2020-01-01 → 2020-12-31 | ¥1.1bn |
| —segment total | depreciation | 2020-01-01 → 2020-12-31 | ¥1.5bn |
| —segment total | revenue | 2020-01-01 → 2020-12-31 | ¥77.6bn |
| —segment total | revenue external | 2020-01-01 → 2020-12-31 | ¥77.6bn |
| —segment total | revenue intersegment | 2020-01-01 → 2020-12-31 | ¥9m |
| —segment total | segment assets | at 2020-12-31 | ¥47.9bn |
| —segment total | segment profit | 2020-01-01 → 2020-12-31 | ¥2.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2019-01-01 → 2019-12-31 | ¥0 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2019-01-01 → 2019-12-31 | ¥51m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2019-01-01 → 2019-12-31 | ¥51m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2019-12-31 | ¥40m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2019-01-01 → 2019-12-31 | ¥13m |
| Reconciling Itemsreconciling | capex | 2019-01-01 → 2019-12-31 | ¥270m |
| Reconciling Itemsreconciling | depreciation | 2019-01-01 → 2019-12-31 | ¥153m |
| Reconciling Itemsreconciling | revenue | 2019-01-01 → 2019-12-31 | −¥13m |
| Reconciling Itemsreconciling | revenue intersegment | 2019-01-01 → 2019-12-31 | −¥13m |
| Reconciling Itemsreconciling | segment assets | at 2019-12-31 | ¥3.9bn |
| Enzymatic Medicinereportable segment | capex | 2019-01-01 → 2019-12-31 | ¥211m |
| Enzymatic Medicinereportable segment | depreciation | 2019-01-01 → 2019-12-31 | ¥209m |
| Enzymatic Medicinereportable segment | revenue | 2019-01-01 → 2019-12-31 | ¥4.0bn |
| Enzymatic Medicinereportable segment | revenue external | 2019-01-01 → 2019-12-31 | ¥4.0bn |
| Enzymatic Medicinereportable segment | segment assets | at 2019-12-31 | ¥3.9bn |
| Enzymatic Medicinereportable segment | segment profit | 2019-01-01 → 2019-12-31 | ¥1.1bn |
| Liquorreportable segment | capex | 2019-01-01 → 2019-12-31 | ¥2.4bn |
| Liquorreportable segment | depreciation | 2019-01-01 → 2019-12-31 | ¥934m |
| Liquorreportable segment | revenue | 2019-01-01 → 2019-12-31 | ¥67.4bn |
| Liquorreportable segment | revenue external | 2019-01-01 → 2019-12-31 | ¥67.4bn |
| Liquorreportable segment | revenue intersegment | 2019-01-01 → 2019-12-31 | ¥13m |
| Liquorreportable segment | segment assets | at 2019-12-31 | ¥41.2bn |
| Liquorreportable segment | segment profit | 2019-01-01 → 2019-12-31 | ¥319m |
| Real Estatereportable segment | depreciation | 2019-01-01 → 2019-12-31 | ¥21m |
| Real Estatereportable segment | revenue | 2019-01-01 → 2019-12-31 | ¥340m |
| Real Estatereportable segment | revenue external | 2019-01-01 → 2019-12-31 | ¥340m |
| Real Estatereportable segment | segment assets | at 2019-12-31 | ¥1.1bn |
| Real Estatereportable segment | segment profit | 2019-01-01 → 2019-12-31 | ¥191m |
| Starch For Processingreportable segment | capex | 2019-01-01 → 2019-12-31 | ¥2m |
| Starch For Processingreportable segment | depreciation | 2019-01-01 → 2019-12-31 | ¥66m |
| Starch For Processingreportable segment | revenue | 2019-01-01 → 2019-12-31 | ¥3.7bn |
| Starch For Processingreportable segment | revenue external | 2019-01-01 → 2019-12-31 | ¥3.7bn |
| Starch For Processingreportable segment | segment assets | at 2019-12-31 | ¥2.4bn |
| Starch For Processingreportable segment | segment profit | 2019-01-01 → 2019-12-31 | ¥136m |
| —segment total | capex | 2019-01-01 → 2019-12-31 | ¥2.6bn |
| —segment total | depreciation | 2019-01-01 → 2019-12-31 | ¥1.2bn |
| —segment total | revenue | 2019-01-01 → 2019-12-31 | ¥75.4bn |
| —segment total | revenue external | 2019-01-01 → 2019-12-31 | ¥75.4bn |
| —segment total | revenue intersegment | 2019-01-01 → 2019-12-31 | ¥13m |
| —segment total | segment assets | at 2019-12-31 | ¥48.6bn |
| —segment total | segment profit | 2019-01-01 → 2019-12-31 | ¥1.7bn |
| Liquorreportable segment | employees | at 2020-12-31 | 2 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,662
| Item | Context | Value | Unit |
|---|---|---|---|
| Products freightage and warehousing fee sga | CurrentYearDuration | 4242000000 | JPY |
| Advertising expenses sga | Prior1YearDuration | 242000000 | JPY |
| Advertising expenses sga | CurrentYearDuration | 156000000 | JPY |
| Promotion expenses sga | Prior1YearDuration | 740000000 | JPY |
| Promotion expenses sga | CurrentYearDuration | 576000000 | JPY |
| Directors compensations sga | Prior1YearDuration | 487000000 | JPY |
| Directors compensations sga | CurrentYearDuration | 467000000 | JPY |
| Payrolls and allowances sga | Prior1YearDuration | 2309000000 | JPY |
| Payrolls and allowances sga | CurrentYearDuration | 2218000000 | JPY |
| Bonuses sga | Prior1YearDuration | 811000000 | JPY |
| Bonuses sga | CurrentYearDuration | 824000000 | JPY |
| Provision for directors bonuses sga | Prior1YearDuration | 40000000 | JPY |
| Provision for directors bonuses sga | CurrentYearDuration | 40000000 | JPY |
| Retirement benefit expenses sga | Prior1YearDuration | 189000000 | JPY |
| Retirement benefit expenses sga | CurrentYearDuration | 168000000 | JPY |
| Welfare expenses sga | Prior1YearDuration | 610000000 | JPY |
| Welfare expenses sga | CurrentYearDuration | 591000000 | JPY |
| Taxes and dues sga | Prior1YearDuration | 409000000 | JPY |
| Taxes and dues sga | CurrentYearDuration | 395000000 | JPY |
| Business consignment expenses sga | Prior1YearDuration | 35000000 | JPY |
| Business consignment expenses sga | CurrentYearDuration | 31000000 | JPY |
| Depreciation sga | Prior1YearDuration | 222000000 | JPY |
| Depreciation sga | CurrentYearDuration | 162000000 | JPY |
| Rent expenses sga | Prior1YearDuration | 452000000 | JPY |
| Rent expenses sga | CurrentYearDuration | 444000000 | JPY |
| Amortization of goodwill sga | Prior1YearDuration | 63000000 | JPY |
| Amortization of goodwill sga | CurrentYearDuration | 63000000 | JPY |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period | Prior1YearDuration | 511000000 | JPY |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period | CurrentYearDuration | 515000000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E00397-000LiquorReportableSegmentsMember | 67357000000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E00397-000StarchForProcessingReportableSegmentsMember | 3708000000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E00397-000EnzymaticMedicineReportableSegmentsMember | 3986000000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E00397-000RealEstateReportableSegmentsMember | 340000000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReportableSegmentsMember | 75392000000 | JPY |
| Revenues from external customers | Prior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 51000000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YearDuration | 75444000000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E00397-000LiquorReportableSegmentsMember | 13000000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E00397-000StarchForProcessingReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E00397-000EnzymaticMedicineReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E00397-000RealEstateReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_ReportableSegmentsMember | 13000000 | JPY |
| Transactions with other segments | Prior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_ReconcilingItemsMember | -13000000 | JPY |
| Transactions with other segments | Prior1YearDuration | － | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E00397-000LiquorReportableSegmentsMember | 67371000000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E00397-000StarchForProcessingReportableSegmentsMember | 3708000000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E00397-000EnzymaticMedicineReportableSegmentsMember | 3986000000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E00397-000RealEstateReportableSegmentsMember | 340000000 | JPY |
| Net sales | Prior1YearDuration_ReportableSegmentsMember | 75406000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |